RHYTHM PHARMACEUTICALS, INC.
RYTM
43 insider filings · Latest: Sep 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Sep 14 11:37 PM | David P MeekerDirector, President and CEO | Sale | 50,000 | $102.67 | $5.1M | 239,258(D) | View → |
| Sep 14, 2026 | Sep 14 8:49 PM | David Meeker | Proposed Sale | 50,000 | $104.71 | $5.2M | — | View → |
| Aug 31, 2026 | Sep 1 8:22 PM | Hunter C SmithChief Financial Officer | Sale | 62,774 | $105.46 | $6.6M | 114,024(D) | View → |
| Aug 31, 2026 | Aug 31 8:32 PM | HUNTER SMITH | Proposed Sale | 62,774 | $107.17 | $6.7M | — | View → |
| Aug 13, 2026 | Aug 17 10:00 PM | Joseph ShulmanChief Technical Officer | Sale | 5,079 | $119.75 | $608.2K | 15,915(D) | View → |
| Aug 13, 2026 | Aug 17 9:57 PM | Alastair GarfieldChief Scientific Officer | Sale | 7,763 | $117.57 | $912.7K | 2,295(D) | View → |
| Aug 13, 2026 | Aug 14 11:04 PM | Jennifer Kayden LeeEVP, Head of North America | Sale | 75,834 | $117.38 | $8.9M | 0(D) | View → |
| Aug 12, 2026 | Aug 14 11:01 PM | Yann MazabraudEVP, Head of International | Sale | 57,000 | $116.15 | $6.6M | 55,655(D) | View → |
| Aug 13, 2026 | Aug 13 8:51 PM | ALASTAIR GARFIELD | Proposed Sale | 7,763 | $117.60 | $912.9K | — | View → |
| Aug 13, 2026 | Aug 13 8:40 PM | JOSEPH J SHULMAN | Proposed Sale | 5,079 | $117.60 | $597.3K | — | View → |
| Aug 13, 2026 | Aug 13 8:39 PM | Jennifer Kayden Lee | Proposed Sale | 75,834 | $117.60 | $8.9M | — | View → |
| Aug 12, 2026 | Aug 12 8:34 PM | YANN MAZABRAUD | Proposed Sale | 57,000 | $112.85 | $6.4M | — | View → |
| Aug 11, 2026 | Aug 11 8:30 PM | PAMELA CRAMER | Proposed Sale | 11,406 | $115.48 | $1.3M | — | View → |
| Aug 10, 2026 | Aug 10 8:33 PM | PAMELA CRAMER | Proposed Sale | 3,520 | $115.63 | $407.0K | — | View → |
| Jun 22, 2026 | Jun 24 8:15 PM | Lynn A. TetraultDirector | Sale | 37,000 | $100.32 | $3.7M | 7,000(D) | View → |
| Jun 22, 2026 | Jun 22 8:49 PM | LYNN TETRAULT | Proposed Sale | 37,000 | $96.79 | $3.6M | — | View → |
| May 15, 2026 | May 19 8:15 PM | Christopher Paul GermanCorporate Controller & CAO | Sale | 4,643 | $92.21 | $428.1K | 0(D) | View → |
| Mar 4, 2026 | Mar 6 9:51 PM | Christopher Paul GermanCorporate Controller & CAO | Sale | 5,614 | $89.56 | $502.8K | 160(D) | View → |
| Mar 4, 2026 | Mar 4 9:14 PM | CAMILLE L BEDROSIAN | Proposed Sale | 64,540 | $90.62 | $5.8M | — | View → |
| Mar 3, 2026 | Mar 3 9:05 PM | CAMILLE L BEDROSIAN | Proposed Sale | 35,460 | $90.52 | $3.2M | — | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 1, 2026 | Feb 3 9:32 PM | Christopher Paul GermanCorporate Controller & CAO | Option Exercise | 3,613 | — | 5,418(D) | View → |
| Feb 1, 2026 | Feb 3 9:31 PM | Alastair GarfieldChief Scientific Officer | Option Exercise | 6,663 | — | 19,987(D) | View → |
| Feb 1, 2026 | Feb 3 9:30 PM | Pamela J. CramerChief Human Resources Officer | Option Exercise | 13,293 | — | 15,000(D) | View → |
← Previous
Page 3 of 3